News & Analysis on Clinical Trial Services & Contract Research And Development
The expansion of the European Union to include 25 member states after May 2004 presents significant opportunities for the pharmaceutical industry to tap new markets, but companies should think twice before launching new products there.
A new finding may lead to new treatments for multiple myeloma, an incurable cancer of immune cells called plasma cells that are present in the blood and bone marrow.
Serono has licensed rights to a drug that takes a novel approach to the treatment of ulcerative colitis, a common disease that is asociated with debilitating symptoms, including cancer, but remains poorly treated with existing drugs.
Scientists in the US have developed a new software package that can predict the activity of enzymes, potentially improving the design of new drugs and industrial reagents.